Dublin, July 24, 2025 (GLOBE NEWSWIRE) -- The "Women`s Healthcare - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Women`s Healthcare was estimated at US$9.7 Billion in 2024 and is projected to reach US$12.1 Billion by 2030, growing at a CAGR of 3.8% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Women`s Healthcare market. 
What Is Driving the Global Growth and Long-Term Potential of the Women's Healthcare Market?
The growth in the women's healthcare market is driven by a confluence of demographic, technological, economic, and sociopolitical factors that together underscore the importance and urgency of investing in gender-specific health solutions. One of the primary drivers is the rising global female population coupled with increased life expectancy, which is resulting in higher demand for long-term care related to aging, hormonal changes, and chronic illness management. Economic empowerment and higher educational attainment among women are also contributing to a more health-literate consumer base that actively seeks preventive care and personalized treatment options.
The increasing availability and affordability of health technologies, from fertility diagnostics to telemedicine platforms, are expanding access and enabling earlier interventions, particularly in emerging economies where healthcare infrastructure is improving rapidly. Venture capital investment in femtech and women-centric health startups is infusing the market with innovation and helping address historically neglected areas. In parallel, multinational pharmaceutical companies are launching new therapeutics tailored to conditions affecting women, from hormone therapies to targeted cancer treatments. Regulatory bodies are responding by streamlining approval pathways for female-specific drugs and devices, further accelerating market development.
Corporate wellness programs and workplace health initiatives are also beginning to recognize and address women's unique health challenges, fostering better health outcomes and productivity. These interconnected drivers reflect a sustained commitment to closing the gender gap in healthcare, ensuring that women receive the attention, research, and medical advancements long overdue. The trajectory of the women's healthcare market points toward continued global expansion, supported by a growing awareness that empowering women's health is foundational to the well-being of families, communities, and economies.
Why Is Women's Healthcare Emerging as a Distinct and Prioritized Sector in Global Health?
Women's healthcare is rapidly evolving as a specialized domain within the broader healthcare ecosystem, reflecting the growing awareness that women have unique physiological, hormonal, and reproductive health needs across different life stages. Unlike traditional healthcare models that often generalized treatments for both genders, modern medicine increasingly recognizes the importance of gender-specific diagnostics, treatments, and preventive care.
The prioritization of women's health stems from a history of underrepresentation in clinical research and systemic neglect, which has led to misdiagnoses and suboptimal care for female patients. Today, governments, healthcare providers, and global organizations are placing a stronger emphasis on addressing these disparities by tailoring services that focus on menstrual health, fertility, pregnancy, menopause, breast and gynecological cancers, osteoporosis, and autoimmune diseases, among others. Social movements and advocacy efforts have brought attention to issues like endometriosis, postpartum depression, and contraceptive access, prompting better policy responses and funding allocation.
In addition, an aging female population worldwide is increasing demand for chronic disease management related to cardiovascular health, bone density, and hormone regulation. By recognizing that women's healthcare needs extend far beyond reproductive care, the medical community is taking steps to develop a more comprehensive and equitable system that ensures timely, accurate, and gender-sensitive care for women of all ages and backgrounds.
How Are Technological Innovations Revolutionizing the Women's Healthcare Landscape?
Technology is playing a transformative role in reshaping the women's healthcare landscape, making care more personalized, accessible, and data-driven. One of the most impactful developments is the proliferation of digital health tools such as mobile apps, wearable devices, and telehealth platforms that enable women to track their menstrual cycles, monitor pregnancy progress, access contraception advice, and manage chronic conditions from the comfort of their homes.
Fertility tech, including ovulation trackers and AI-assisted in vitro fertilization (IVF) platforms, is empowering women with more control over their reproductive timelines. Diagnostic technologies have also improved, enabling earlier detection of diseases such as breast and ovarian cancer through advanced imaging and genetic testing. Remote consultations have become especially important in rural and underserved areas, where women often face barriers related to mobility, stigma, or lack of nearby specialists. In addition, electronic health records and predictive analytics are helping clinicians tailor treatment plans based on individual patient profiles, improving outcomes in areas like hormonal therapy and prenatal care.
Startups and femtech companies are leading the charge by developing innovative solutions such as non-invasive diagnostics, digital pelvic floor trainers, and mental health platforms that cater specifically to women's unique needs. These innovations are not only enhancing clinical care but also breaking down longstanding taboos and promoting a culture of health empowerment, allowing women to take an active role in their well-being with unprecedented ease and confidence.
What Societal Shifts and Policy Changes Are Influencing the Women's Healthcare Market?
Societal awareness and policy reforms are playing an increasingly important role in shaping the direction and momentum of the women's healthcare market. Around the world, women are demanding better access to quality healthcare, equal representation in clinical research, and stronger protections against health inequities, leading to more robust public discourse and legislative action. Governments and health agencies are enacting policies to expand coverage for maternal care, fertility treatments, contraception, and cancer screenings, often under broader gender equality or universal healthcare frameworks.
The global conversation around menstrual equity is prompting institutions to provide free sanitary products and education, helping dismantle the stigma that surrounds menstruation. Additionally, the rising visibility of women's mental health challenges, including postpartum depression and anxiety disorders, is prompting a shift toward more inclusive and integrated mental healthcare services. Insurance providers are also beginning to include more comprehensive women's health benefits, reflecting market demand for better preventive care and long-term wellness solutions. Media and advocacy campaigns continue to amplify the voices of those affected by chronic yet underdiagnosed conditions such as polycystic ovary syndrome (PCOS), fibroids, and perimenopause symptoms, prompting the medical community to invest in research and education.
These societal and regulatory shifts are not only improving access to care but also reshaping cultural narratives around female health, affirming that women's medical concerns are both valid and deserving of systemic support. The result is a more informed, engaged, and empowered patient base that expects healthcare systems to evolve in step with their needs.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as AbbVie, Astellas Pharma, AstraZeneca, Ava Women, Besins Healthcare and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Hormonal Infertility Application segment, which is expected to reach US$3.1 Billion by 2030 with a CAGR of a 3.4%. The Postmenopausal Osteoporosis Application segment is also set to grow at 2.6% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $2.6 Billion in 2024, and China, forecasted to grow at an impressive 6.8% CAGR to reach $2.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Scope Of Study:
- Application (Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application, Other Applications)
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 189 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value in 2024 | 9.7 Billion |
| Forecasted Market Value by 2030 | 12.1 Billion |
| Compound Annual Growth Rate | 3.8% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Tariff Impact on Global Supply Chain Patterns
- Women`s Healthcare - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
MARKET TRENDS & DRIVERS
- Rising Awareness of Gender-Specific Health Needs Throws the Spotlight on Women`s Healthcare as a Global Priority
- Shift Toward Preventive Care Models Spurs Demand for Early Diagnosis and Screening Services Across Female Health Conditions
- Here`s How Digital Health Platforms Are Expanding Access to Reproductive and Menstrual Health Management
- Increased Focus on Maternal Health and Safe Childbirth Strengthens the Business Case for Integrated Prenatal Care Solutions
- Investment in Fertility Services and Egg Freezing Expands the Addressable Market Opportunity in Reproductive Technologies
- Aging Female Population and Menopause Management Drive Innovation in Hormone Therapy and Lifestyle Interventions
- Rising Mental Health Awareness Among Women Fuels Demand for Gender-Sensitive Therapy and Support Programs
- Here`s How FemTech Startups Are Disrupting Traditional Care Models with Personalized, App-Based Solutions
- Growth in Gynecological Oncology Screening and Treatment Accelerates Adoption of Advanced Diagnostics and Surgical Tools
- Workplace Wellness Programs and Corporate Benefits Support Expansion of Holistic Women-Centered Care Offerings
- Access to Contraceptive Options and Family Planning Services Sustains Progress in Reproductive Autonomy and Choice
- Global Rise in Polycystic Ovary Syndrome (PCOS), Endometriosis, and Autoimmune Disorders Highlights Unmet Needs in Women`s Health
FOCUS ON SELECT PLAYERS |Some of the 36 companies featured in this Women`s Healthcare market report include:
- AbbVie
- Astellas Pharma
- AstraZeneca
- Ava Women
- Besins Healthcare
- Bonzun
- Duchesnay
- Flo Health
- Lilly (Eli Lilly)
- Mayne Pharma
- Medicines360
- Midi Health
- Morgan Stanley Inclusive Lab
- Natural Cycles
- Organon
- Pfizer
- Pristyn Care
- Roche
- Ru Medical (Unpause)
- Sanofi
For more information about this report visit https://www.researchandmarkets.com/r/2oolg2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
